Mei-Shi Announces Board Decision to Cancel Fund Lending to Subsidiary
AI Summary (NQ-processed)
Mei-Shi Chemical Pharmaceutical Co., Ltd. has announced that its board has approved the cancellation of a USD 20 million fund lending arrangement to its subsidiary, Lotus International Pte. Ltd., citing operational adjustments.
AI Analysis
Frequently Asked Questions
Q: Why did Mei-Shi cancel the fund lending?
A: To align with current operations and improve capital efficiency. No funds were disbursed, so no loss occurred.
Q: Will this affect Mei-Shi's stock price?
A: The company states no significant impact on shareholder权益 or securities prices.
Q: What happens to Lotus International now?
A: Operations continue, but future funding remains under review.